» Articles » PMID: 18940301

Native Valve Infective Endocarditis in a Tertiary Care Center in a Developing Country (Tunisia)

Overview
Journal Am J Cardiol
Date 2008 Oct 23
PMID 18940301
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the study was to describe the epidemiological and clinical aspects of native valve infective endocarditis (IE) in a Tunisian high-volume tertiary care center and to identify the predictors of outcome. Demographic, clinical, laboratory, and echocardiographic characteristics were examined in 134 patients who fulfilled the modified Duke criteria for native valve IE between January 1997 and December 2006. Logistic regression analysis was used to identify prognostic factors for death. Mean age was 34.22 years. Diagnosis was definite in 93% of cases. Median time to diagnosis was 21 days. Rheumatic heart disease (RHD) was the predominant (45%) underlying heart condition. One or more vegetations were detected in more than 93% of cases. The median size of vegetation was >15 mm in 28% of cases. In 66 cases (49%), cultures remained negative. Serology was positive in 15 cases, and in 4 cases leaflet culture identified the agent. The infective agent was identified in 87 cases (65%), causative microorganisms were mainly Staphylococci (n = 30, including 6 coagulase-negative Staphylococcus), and Streptococci (n = 32). Overall mortality was 19%. On multivariate analysis, congestive heart failure (hazard ratio = 5.34, 95% confidence interval 1.67 to 17.15, p = 0.005) and large vegetations (>15 mm; hazard ratio = 5.78, 95% confidence interval 1.84 to 18.32, p = 0.002) were predictive of in-hospital mortality but not neurological complications or staphylococcus IE. In conclusion, IE remains a serious disease affecting a young population in Tunisia, with RHD as still the most common underlying heart disease, and it is associated with a high mortality.

Citing Articles

Infective endocarditis in developing countries: An update.

Mutagaywa R, Vroon J, Fundikira L, Wind A, Kunambi P, Manyahi J Front Cardiovasc Med. 2022; 9:1007118.

PMID: 36172579 PMC: 9510687. DOI: 10.3389/fcvm.2022.1007118.


Endocarditis in the Mediterranean Basin.

Gouriet F, Chaudet H, Gautret P, Pellegrin L, de Santi V, Savini H New Microbes New Infect. 2018; 26:S43-S51.

PMID: 30402243 PMC: 6205568. DOI: 10.1016/j.nmni.2018.05.004.


Infective endocarditis; report from a main referral teaching hospital in Iran.

Heydari B, Karimzadeh I, Khalili H, Shojaei E, Ebrahimi A Iran J Pharm Res. 2017; 16(1):390-398.

PMID: 28496492 PMC: 5423264.


Evaluation of epidemiological, clinical, and microbiological features of definite infective endocarditis.

Faraji R, Behjati-Ardakani M, Moshtaghioun S, Kalantar S, Namayandeh S, Soltani M GMS Hyg Infect Control. 2017; 12:Doc01.

PMID: 28149706 PMC: 5241444. DOI: 10.3205/dgkh000286.


Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN.

DeSimone D, Tleyjeh I, Correa de Sa D, Anavekar N, Lahr B, Sohail M Am Heart J. 2015; 170(4):830-6.

PMID: 26386808 PMC: 4677064. DOI: 10.1016/j.ahj.2015.07.007.